Watch this CME-certified on-demand Webcast of a CCO symposium at ASCO GU 2019 to gain expert perspectives on the evolving role of PARP inhibitors in advanced prostate cancer, including an overview of BRCA and other DNA repair deficiencies, guidance on genetic testing, review of the latest clinical data, and a panel case discussion.
Download this slideset to review the clinical implications of genetic testing for DNA repair mutations in localized and advanced prostate cancer, including an expert case discussion.
Download this slideset to get up to date on the latest clinical evidence for PARP inhibition in the care of patients with advanced prostate cancer.
Download this slideset to review the most clinically relevant DNA repair mutations in advanced prostate cancer and their implications for patient care.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.